Episode
Astaxanthin Explained: Longevity, Heart Health & Bioavailability with Dave Watumull
- Podcast
- The Strong New York Podcast
- Published
- Apr 8, 2026
- Duration seconds
- 3247
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/b0290100
Actions
POST https://stenobird.com/v1/public/podcasts/the-strong-new-york-podcast-6922708/episodes/astaxanthin-explained-longevity-heart-health-bioavailability-with-dave-watumull/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-strong-new-york-podcast-6922708/astaxanthin-explained-longevity-heart-health-bioavailability-with-dave-watumull.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This week on the Strong New York Podcast, host Kenny Santucci interviews David Watumull, co-founder and CEO of AX3 Life, a longevity company focused on helping people perform at their best for longer. Dave explains the science behind inflammaging — chronic inflammation linked to aging — and how AX3’s bio-pure astaxanthin is designed to address it at the source. Kenny and Dave discuss why astaxanthin is emerging as a foundational daily nutrient for longevity, supporting cognition, heart health, endurance, recovery, and skin and eye health. Dave also breaks down how it works in the body, the growth of research in this space, and clinical findings related to oxidative stress and LDL. They also explore the history of astaxanthin, the challenges of building awareness in the longevity category, and practical details including dosing, packaging, and pricing. A thoughtful conversation on performance, recovery, and the future of longevity science. 00:00 Podcast intro and guest 00:25 First look at astaxanthin 00:52 How to take it and feel it 01:21 Why the pouch packaging 02:16 Cellular benefits explained 04:00 Research and safety proof 05:45 Origin story and setbacks 08:10 Marketing and investor hurdles 10:51 Elevator pitch and daily stack 13:30 Where it comes from and extraction 16:41 Awareness and education challenge 19:24 Growth channels and target users 24:03 Advocates and NIH lifespan study 27:23 Where the brand goes next 27:48 Astaxanthin with Omega-3s 28:53 LDL and Heart Risk 31:03 Inflammation and hsCRP 32:00 Origin Story and Mission 35:55 Dosing and Expectations 37:28 Cost and Value Debate 39:34 Bioavailability Comparison 40:35 Vision for Mass Adoption 42:02 Workout Routine and Community 46:05 Skin and Exercise Benefits 48:26 NAD and Mitochondria 50:11 How to Take It Da…